| Annual Financials | 2020 | 2021 | 2022 | TTM |
Revenue  | 216 | 249 | 342 | 0 |
| Expenses | 176 | 194 | 264 | 0 |
| EBITDA | 40 | 55 | 79 | 0 |
| Operating Profit % | 17 % | 20 % | 22 % | 0 % |
| Depreciation | 11 | 13 | 14 | 0 |
| Interest | 14 | 14 | 11 | 0 |
| Profit Before Tax | 15 | 29 | 54 | 0 |
| Tax | 4 | 8 | 12 | 0 |
| Net Profit | 11 | 21 | 42 | 0 |
| EPS in ₹ | 4.11 | 7.92 | 5.22 | 0.00 |
GPT Healthcare
GPT Healthcare
141.91
-0.93
(-0.65%)
Market Cap
1,164.44 Cr
PE Ratio
25.82
Volume
81,271.00
Day High - Low
144.99 - 140.04
52W High-Low
185.00 - 115.00
Q3 Quarterly Results are out. Check out the updated financials1 day ago
Show All
Key Fundamentals
Market Cap
1,164.44 Cr
EPS
5.22
PE Ratio
25.82
PB Ratio
5.90
Book Value
32.83
EBITDA
78.80
Dividend Yield
2.67 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
26.34
Debt to Equity
0.76
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
GPT Healthcare Outlines FY27 Growth Guidance16 hrs ago
GPT Healthcare projects 15% revenue growth and ~20.2% EBITDA margin for FY27, with ARPOB rising ~8%, new hospital commissions, and occupancy targets across key units.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (+15.14% YoY) and PAT of ₹42.2 Cr. Q4 revenue grew 24.30% YoY to ₹128.0 Cr. Total dividend of ₹2.50/share declared.
GPT Healthcare has scheduled a Board of Directors meeting on May 18, 2026, to consider audited financial results for Q4 and FY2025-26, and to recommend a final dividend.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,078.50 | #1 1,16,156.44 | 61.85 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 63.02 | |
1,075.70 | 1,04,680.14 | 73.17 | 7,184.10 | #1 28.68 | 1,076 | 26.01 | 69.22 | |
974.60 | 73,578.22 | 73.91 | 7,849.70 | 13.25 | 809 | -22.38 | 64.39 | |
764.85 | 39,628.49 | 90.83 | 4,643.22 | 8.32 | 384 | #1 79.65 | 67.84 | |
1,902.40 | 38,877.60 | 49.39 | 5,575.00 | 12.29 | 790 | -34.33 | 63.15 | |
1,240.10 | 33,332.70 | 59.95 | 4,410.27 | 16.94 | 584 | 39.64 | 66.61 | |
755.80 | 30,242.50 | 122.49 | 3,904.60 | 27.31 | 198 | -68.80 | 60.28 | |
459.70 | 14,563.64 | 90.00 | 1,757.00 | 27.64 | 110 | 54.61 | 57.24 | |
1,342.00 | 13,629.24 | 52.82 | 1,566.90 | 17.46 | 244 | 7.26 | 64.55 | |
256.21 | 11,066.50 | #1 39.07 | 1,679.36 | 17.77 | 272 | 46.56 | 65.94 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 |
| Total Assets | 309 | 317 | 323 |
| Fixed Assets | 226 | 220 | 220 |
| Current Assets | 63 | 86 | 86 |
| Capital Work in Progress | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| Other Assets | 80 | 97 | 92 |
| Total Equity & Liabilities | 309 | 317 | 323 |
| Current Liabilities | 65 | 60 | 69 |
| Non Current Liabilities | 117 | 123 | 97 |
| Total Equity | 127 | 134 | 158 |
| Reserve & Surplus | 69 | 76 | 78 |
| Share Capital | 18 | 18 | 80 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 |
| Net Cash Flow | -1 | 4 | 4 |
| Investing Activities | -54 | -17 | -5 |
| Operating Activities | 42 | 43 | 66 |
| Financing Activities | 12 | -22 | -57 |
Share Holding
| % Holding | Oct 2021 | Oct 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 99.97 % | 67.34 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 6.68 % | 5.38 % | 4.70 % | 4.72 % | 4.48 % | 4.96 % | 3.20 % | 2.74 % | 2.81 % |
| DIIs | 0.00 % | 0.00 % | 10.07 % | 12.81 % | 13.08 % | 11.99 % | 11.30 % | 11.35 % | 9.32 % | 6.46 % | 6.20 % | 6.84 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 17.14 % | 12.16 % | 13.61 % | 15.07 % | 15.33 % | 15.55 % | 16.65 % | 18.89 % | 19.11 % | 18.33 % |
| Others | 0.03 % | 32.66 % | 7.22 % | 2.78 % | 2.35 % | 2.66 % | 3.08 % | 3.04 % | 3.50 % | 5.87 % | 6.38 % | 6.45 % |
| No of Share Holders | 9 | 9 | 9 | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 | 66,626 | 64,075 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5 | 3.5 | 2.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84 | 2.38 | 2.17 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Aug 2026 |  Annual General Meeting | NA | 06 Aug 2026 | 141.55 | 142.84 |
| 02 Apr 2024 |  Dividend | ₹ 1.00 /share | 02 Apr 2024 | 167.25 | 177.30 |
| 18 Jul 2024 | Dividend | ₹ 1.50 /share | 18 Jul 2024 | 162.50 | 170.95 |
| 25 Jul 2024 | Annual General Meeting | NA | 25 Jul 2024 | 162.50 | 167.99 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 173.64 | 163.54 |
| 28 Nov 2024 | Dividend | ₹ 1.00 /share | 28 Nov 2024 | 163.54 | 173.98 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 178.93 | 161.60 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 156.88 | 155.00 |
| 29 Jul 2025 | Dividend | ₹ 1.50 /share | 29 Jul 2025 | 155.00 | 159.63 |
| 05 Aug 2025 | Annual General Meeting | NA | 05 Aug 2025 | 155.00 | 183.40 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 161.35 | 180.01 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 149.82 | 147.35 |
| 14 Nov 2025 | Dividend | ₹ 1.00 /share | 14 Nov 2025 | 147.35 | 143.45 |
| 02 Feb 2026 | Quarterly Result Announcement | NA | 02 Feb 2026 | 129.40 | 128.80 |
| 18 May 2026 | Quarterly Result Announcement | NA | 18 May 2026 | 144.35 | 141.55 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
10 hrs ago
10 hrs agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation2 days ago
2 days agoCorporate Action-Board approves Dividend2 days ago
2 days agoCorporate Action-Fixes Book Closure For 37Th Annual General Meeting2 days ago
2 days agoResults-Financial Results For Q4FY2025262 days ago
2 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On May 18 20262 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoBoard Meeting Intimation for Approval Of Audited Results And Recommendation Of Final Dividend If Any.9 days ago
9 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 02, 2026
Apr 02, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Mar 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 03, 2026
Feb 03, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 02, 2026
Feb 02, 2026Un-Audited Financial Results For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025Feb 02, 2026
Feb 02, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On February 2 2026Feb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Jan 27, 2026Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 3Rd Quarter And Nine Months (Q3 & 9MFY26) Ended December 31 2025.Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Appointment Of MUFG Intime India Private Ltd For Providing Investor Relations Advisory Services.Dec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Nov 08, 2025Results-Unaudited Financial Results For The 2Nd Quarter And Half Year Ended September 30 2025.Nov 08, 2025
Nov 08, 2025Corporate Action- Board Fixes Record Date For Interim DividendNov 08, 2025
Nov 08, 2025Corporate Action-Board approves DividendNov 08, 2025
Nov 08, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On November 8 2025Nov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Nov 04, 2025Board Meeting Intimation for Considering Inter Alia And Approving The Unaudited Financial Results Of The Company For The 2Nd Quarter And Half Year Ended On September 30 2025 And To Declare Interim Dividend For The Financial Year 2025-26.Oct 31, 2025
Oct 31, 2025Appointment (Regularization) Of Mr. Shree Gopal Tantia Promoter (DIN:00001346) As Non-Executive Director Of The CompanyOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 29, 2025
Oct 29, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 29, 2025
Oct 29, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Intimation Regarding 100 Days Campaign-Saksham NiveshakSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 24, 2025
Sep 24, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On September 24 2025Sep 24, 2025
Sep 24, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Axis Balanced Advantage Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Axis Multi Asset Allocation Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | 0 | 0.00% | 0.01% | |
Bandhan Infrastructure Fund Direct Plan-Growth | 0.51% | 0 | 0.00% | -0.02% | |
Bandhan Retirement Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Bandhan Small Cap Fund Direct-Growth | 0.18% | 0 | 0.00% | -0.01% | |
 Kotak Equity Savings Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Kotak Multi Asset Allocation Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 59.96
ATR(14)
Less Volatile 4.99
STOCH(9,6)
Neutral 47.43
STOCH RSI(14)
Neutral 25.04
MACD(12,26)
Bearish -0.42
ADX(14)
Strong Trend 27.77
UO(9)
Bearish 52.45
ROC(12)
Uptrend And Accelerating 3.19
WillR(14)
Neutral -35.04
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
